Clinical Trial Update: Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

View source ↗

Summary

This clinical trial investigates whether controlling serum uric acid improves survival after pancreatic cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province | Conditions: Serum Uric Acid | Status: RECRUITING